Prothena reported 39.1M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 102.18M 13.03M
Bluebird Bio BLUE:US $ 137.27M 102.36M
IONIS PHARMACEUT IONS:US $ 219M 0.06M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Prothena PRTA:US 39.1M 4.83M
Vital Therapies VTL:US $ 21.44M 286K
Xoma XOMA:US $ 5.17M 408K